SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endo International plc - ENDP

Saturday, June 24, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 23, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf

of investors of Endo International plc ("Endo" or the "Company") (NASDAQ:  ENDP).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.

The

investigation concerns whether Endo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here to join a class action]

On May 15, 2017, post-market, Reuters reported that Orange County, New York had sued Endo, along with other pharmaceutical companies, accusing the Company of engaging in fraudulent marketing that downplayed the risks of prescription opioid painkillers.  On this news, Endo's share price fell $0.94, or 6.98%, over the following two trading days to close at $12.52 on May 17, 2017. 

On June 8, 2017, the U.S. Food and Drug Administration instructed Endo to pull its opioid painkiller Opana ER from the U.S. market, citing Opana's "high risk of abuse and potential to help spread HIV and hepatitis C."  On this news, Endo's share price fell $2.29 or 6.62%, to close at $11.49 on June 19, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:Robert S. WilloughbyPomerantz LLP[email protected]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-endo-international-plc---endp-300479173.html

SOURCE Pomerantz LLP



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store